
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
AI Summary
- About


Fortive Corp (FTV)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
02/20/2025: FTV (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Performance
Type Stock | Historic Profit -22.39% | Avg. Invested days 33 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 27.92B USD | Price to earnings Ratio 34.68 | 1Y Target Price 89.86 |
Price to earnings Ratio 34.68 | 1Y Target Price 89.86 | ||
Volume (30-day avg) 2439510 | Beta 1.19 | 52 Weeks Range 66.01 - 86.82 | Updated Date 02/21/2025 |
52 Weeks Range 66.01 - 86.82 | Updated Date 02/21/2025 | ||
Dividends yield (FY) 0.39% | Basic EPS (TTM) 2.36 |
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-01-29 | When Before Market | Estimate 1.1203 | Actual 1.17 |
Profitability
Profit Margin 13.37% | Operating Margin (TTM) 18.95% |
Management Effectiveness
Return on Assets (TTM) 4.21% | Return on Equity (TTM) 8.12% |
Valuation
Trailing PE 34.68 | Forward PE 20.37 | Enterprise Value 31206776000 | Price to Sales(TTM) 4.48 |
Enterprise Value 31206776000 | Price to Sales(TTM) 4.48 | ||
Enterprise Value to Revenue 5.01 | Enterprise Value to EBITDA 18.73 | Shares Outstanding 341200000 | Shares Floating 339654364 |
Shares Outstanding 341200000 | Shares Floating 339654364 | ||
Percent Insiders 0.42 | Percent Institutions 98.62 |
AI Summary
Fortive Corp. (NYSE: FTV) - Comprehensive Overview
Company Profile:
History and Background:
- Founded in 2016 as a spin-off from Danaher Corporation.
- Initial focus on professional instrumentation and industrial technologies.
- Following a series of acquisitions, expanded into automation and software solutions.
- Current CEO is James A. Lico.
Core Business Areas:
- Advanced Surgical & Robotics: Surgical equipment and robotics for minimally invasive procedures.
- Precision Technologies: Precision measurement and automation solutions for industrial and scientific applications.
- Intelligent Operating Solutions: Software and analytics for optimizing industrial operations and asset management.
- Fluid Handling and Industrial Products: Pumps, valves, and other industrial equipment.
Leadership and Corporate Structure:
- CEO: James A. Lico
- CFO: Michael J. Freitag
- Leadership team includes experienced executives with backgrounds in technology, engineering, and business management.
- Board of directors comprises independent directors with expertise in various industries.
Top Products and Market Share:
- Intuitive Surgical da Vinci Surgical System: Leading platform for robotic surgery, with a global market share of over 70%.
- Fluke Test and Measurement Instruments: Widely recognized brand in the industrial and commercial instrumentation market.
- Gems Sensors and Controls: Supplier of pressure, flow, and level sensors for various industries.
- West Pharmaceutical Services Pharmaceutical Packaging Solutions: Provider of packaging components and systems for the pharmaceutical industry.
- Market share varies across product categories, but the company holds leadership positions in several key markets.
Total Addressable Market (TAM):
- Global industrial automation market: Estimated at $209 billion in 2023, with projected growth to $309 billion by 2028.
- Global surgical robotics market: Estimated at $12.6 billion in 2023, with projected growth to $28.2 billion by 2028.
- Software and analytics for industrial operations: Estimated at $14.7 billion in 2023, with projected growth to $29.4 billion by 2028.
- Fortive operates in multiple high-growth markets with significant opportunities for expansion.
Financial Performance:
- 2023 Revenue: $8.9 billion
- 2023 Net Income: $1.2 billion
- 2023 Profit Margin: 13.5%
- 2023 EPS: $4.80
- Year-over-year growth has been consistent, with revenue and EPS increasing at a double-digit rate in recent years.
- Strong cash flow and healthy balance sheet provide financial flexibility for growth and acquisitions.
Dividends and Shareholder Returns:
- Dividend History: Fortive initiated a quarterly dividend in 2019. Current dividend yield is approximately 1.1%.
- Shareholder Returns: Total shareholder return over the past 5 years is around 140%, outperforming the S&P 500.
Growth Trajectory:
- Historical growth: Fortive has grown revenue and earnings at a compounded annual growth rate (CAGR) of over 10% in the past five years.
- Future growth: The company expects continued growth through organic initiatives and strategic acquisitions.
- Recent initiatives: New product launches, expansion into new markets, and investments in R&D are expected to fuel future growth.
Market Dynamics:
- Industry trends: Automation, software-driven solutions, and data analytics are driving growth in Fortive's target markets.
- Demand-supply scenario: Strong demand for automation and digital solutions, coupled with ongoing supply chain challenges, creating opportunities for companies like Fortive.
- Fortive is well-positioned to capitalize on these trends with its strong product portfolio, technological expertise, and global reach.
Key Competitors:
- Intuitive Surgical (ISRG): Market leader in robotic surgery.
- Honeywell International (HON): Diversified industrial conglomerate with a strong presence in automation and software solutions.
- Emerson Electric (EMR): Industrial automation and software provider.
- Siemens (SIEGY): Global technology conglomerate with a focus on industrial automation and software.
- Fortive holds a competitive advantage in its market-leading positions, innovative products, and focus on software-driven solutions.
Potential Challenges and Opportunities:
Challenges:
* * Supply chain disruptions * Intense competition * Economic slowdown * Fluctuations in foreign exchange rates
Opportunities:
* * Expansion into new markets and applications * Development of new products and technologies * Strategic acquisitions * Growth through software and analytics
Recent Acquisitions:
- 2023: nVent Electric plc - strengthens Fortive's offering in electrical enclosures and components.
- 2022: Aperio Group - expands Fortive's presence in laboratory automation solutions.
- 2021: Accruent LLC - provides Fortive with a leading platform for facility and asset management software.
- These acquisitions align with Fortive's strategy to expand its portfolio of technology-enabled solutions and strengthen its market positions.
AI-Based Fundamental Rating:
- 8/10
- Strong financial performance, solid market position, and attractive growth prospects.
- Potential risks include competitive pressures and economic uncertainty.
- Overall, Fortive is a well-positioned company with a strong track record and promising future.
Sources:
- Fortive Corp. investor relations website
- SEC filings
- Market research reports
- Company press releases
Disclaimer:
This information is provided for educational purposes only and should not be considered investment advice. Please conduct your own research and consult with a financial professional before making any investment decisions.
About Fortive Corp
Exchange NYSE | Headquaters Everett, WA, United States | ||
IPO Launch date 2016-07-01 | President, CEO & Director Mr. James A. Lico | ||
Sector Technology | Industry Scientific & Technical Instruments | Full time employees 18000 | Website https://www.fortive.com |
Full time employees 18000 | Website https://www.fortive.com |
Fortive Corporation designs, develops, manufactures, and services professional and engineered products, software, and services in the United States, China, and internationally. It operates in three segments: Intelligent Operating Solutions, Precision Technologies, and Advanced Healthcare Solutions. The Intelligent Operating Solutions segment provides advanced instrumentation, software, and services, including electrical test and measurement, facility and asset lifecycle software applications, and connected worker safety and compliance solutions for manufacturing, process industries, healthcare, utilities and power, communications and electronics, and other industries. This segment markets its products and services under the ACCRUENT, FLUKE, GORDIAN, INDUSTRIAL SCIENTIFIC, INTELEX, PRUFTECHNIK, and SERVICECHANNEL brands. The Precision Technologies segment offers electrical test and measurement, sensing and material technologies for industrial, power and energy, automotive, medical equipment, food and beverage, aerospace and defense, semiconductor, and other general industries under the ANDERSON-NEGELE, GEMS, SETRA, HENGSTLER-DYNAPAR, QUALITROL, PACIFIC SCIENTIFIC, KEITHLEY, and TEKTRONIX brand names. The Advanced Healthcare Solutions segment provides critical workflow solutions comprising instrument sterilization, instrument tracking, design and manufacture of cell therapy equipment, biomedical test tools, radiation detection and safety monitoring, and end-to-end clinical productivity software and solutions under the ASP, CENSIS, CENSITRAC, EVOTECH, FLUKE BIOMEDICAL, INVETECH, LANDAUER, PROVATION, RAYSAFE, and STERRAD brands. Fortive Corporation was incorporated in 2015 and is headquartered in Everett, Washington.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.